• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

OncoGenex - Articles and news items

OncoGenex’s Phase 3 non-small cell lung cancer trial did not meet primary endpoint

Industry news / 14 October 2016 / Niamh Louise Marriott, Digital Content Producer

OncoGenex’ results, analysed from the Phase 3 trial of custirsen in patients whose non-small cell lung cancer (NSCLC) has progressed following initial…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +